AGP Executive Report
Last update: 4 hours agoMedicare Ambulance Fix: A bipartisan RESCUE Act would update Medicare ambulance fee schedules every three years to better match provider costs, after long-running reimbursement shortfalls. Drug Approvals: Zydus Lifesciences won USFDA final approval for a generic ascorbic acid injection for scurvy, expanding access to an injectable option. Cancer Screening Impact: A long-term study from Sweden’s colorectal screening program links both invitation and actual participation to lower colorectal cancer death risk. Infectious Disease Watch: Delhi is seeing an H1N1 surge, prompting a federal-state review of testing, hospital readiness, and containment steps; meanwhile, the UK warns about serious salmonella symptoms after an imported-egg-linked outbreak. Health Tech & Security: NHS data firms Arcturis and Akrivia agreed a £140m merger to scale real-world patient data services, while US/Canada agencies issued a cyber alert on active attacks targeting Siemens PLCs used in healthcare infrastructure. AI Drug Discovery: SandboxAQ rolled out AQPotency, an AI model for faster early-stage molecule-target strength predictions. Medical Manufacturing Push: India’s devices regulator push is shifting toward more local component manufacturing and value addition, not just assembly.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Why Dealmaking Is Now a Survival Skill: Q&A with Dan Chancellor]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/27726248-935997089-0991aca1f4b5e9567feb583c660440b0655bccf3-1920x1080-200x113.jpeg)
